⌘K
Loading ticker…
Regeneron Pharmaceuticals Inc · Healthcare · Pharmaceutical Products
As of 2026-06-26, Regeneron Pharmaceuticals Inc (REGN) has a 3-month relative strength percentile of 20 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 47. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 2.6%, relative volume 1.03×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
20 is not yet a leadership-grade RS read, Market Stance is 47
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY diluted average shares. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
REGN is in a stage 3 topping pattern, week 5. Currently in a 117-day base; basing ADR 2.6% (broad 2.7%). VCP detected: inconclusive. RS line below base-start high. Distance from 50d / 200d: -5.1% / -9.4%.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
REGN is held by 19 ETFs as of Mar 2026. Top owner: VTI at 0.13% weight, $2.6B notional. Top 3 carry $6.2B.
Top 10 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| VTIVanguard Total Stock Market ETF | 0.13% | $2.6B |
| VOOVanguard S&P 500 ETF | 0.14% | $2.0B |
| QQQInvesco QQQ Trust Series I | 0.45% | $1.7B |
| IVViShares Core S&P 500 ETF | 0.14% | $1.0B |
| SPYState Street SPDR S&P 500 ETF | 0.14% | $910M |
| VTVVanguard Value ETF | 0.33% | $742M |
| XLVState Street Health Care Select Sector SPDR ETF | 1.47% | $567M |
| JEPIJPMorgan Equity Premium Income ETF | 1.22% | $538M |
| JEPQJPMorgan NASDAQ Equity Premium Income ETF | 0.60% | $205M |
| IWDiShares Russell 1000 Value ETF | 0.26% | $180M |
Showing 10 of 19 ETF owners.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | REGN Jan avg: 0.75% median: 0.59% win: 50% σ: 6.43% n: 4 2022-04-12 → 2026-05-29 | REGN Feb avg: 3.00% median: 3.15% win: 100% σ: 2.19% n: 4 2022-04-12 → 2026-05-29 | REGN Mar avg: -0.68% median: -0.76% win: 25% σ: 7.07% n: 4 2022-04-12 → 2026-05-29 | REGN Apr avg: -6.54% median: -7.46% win: 0% σ: 2.62% n: 5 2022-04-12 → 2026-05-29 | REGN May avg: -5.71% median: -8.26% win: 40% σ: 11.24% n: 5 2022-04-12 → 2026-05-29 | REGN Jun avg: 0.23% median: 2.38% win: 50% σ: 8.76% n: 4 2022-04-12 → 2026-05-29 (current) | REGN Jul avg: 2.06% median: 2.97% win: 75% σ: 2.49% n: 4 2022-04-12 → 2026-05-29 | REGN Aug avg: 6.88% median: 8.12% win: 75% σ: 5.09% n: 4 2022-04-12 → 2026-05-29 | REGN Sep avg: 0.92% median: -1.80% win: 25% σ: 12.62% n: 4 2022-04-12 → 2026-05-29 | REGN Oct avg: -0.22% median: 1.73% win: 50% σ: 15.99% n: 4 2022-04-12 → 2026-05-29 | REGN Nov avg: 3.81% median: 3.01% win: 75% σ: 12.54% n: 4 2022-04-12 → 2026-05-29 | REGN Dec avg: -0.88% median: -2.54% win: 25% σ: 5.27% n: 4 2022-04-12 → 2026-05-29 |